Hemorrhagic Stroke Management
Patients with intracerebral hemorrhage (ICH) must be treated as a medical emergency with immediate blood pressure reduction to systolic BP approximately 140 mmHg, rapid reversal of any coagulopathy, and management in a dedicated neuroscience intensive care unit. 1, 2
Acute Management (First 24 Hours)
Initial Assessment and Diagnosis
- Immediate neuroimaging with CT or MRI to confirm diagnosis, location, and extent of hemorrhage 1
- Conduct NIHSS for awake/drowsy patients or GCS for obtunded patients to establish baseline severity 1
- Obtain coagulation studies immediately: platelet count, PTT, INR, and specific tests for DOACs when appropriate 2
- Perform CT angiography, MR angiography, or catheter angiography to exclude underlying vascular lesions (aneurysm, AVM) 1
- Check cardiac troponin and ECG, complete blood count, renal function, glucose, and toxicology screen 2
Blood Pressure Management
This is the most critical modifiable factor in acute ICH:
- Assess BP every 15 minutes until stabilized 1
- Target systolic BP approximately 140 mmHg for patients presenting with SBP 150-220 mmHg 1, 2
- Achieve this target rapidly but avoid overshoot, large variability, or excessive early declines 3
- Use IV calcium channel blockers (preferred in acute setting) or other IV antihypertensives with careful titration 1
- Avoid aggressive lowering if baseline SBP >220 mmHg - proceed more cautiously 3
Critical pitfall: Aggressive BP reduction can worsen cerebral perfusion. Monitor neurological status continuously during BP lowering.
Coagulopathy Reversal
Anticoagulant-related hemorrhages require immediate reversal:
- For warfarin (INR >1.7): Administer vitamin K plus prothrombin complex concentrate or fresh frozen plasma 2
- For DOACs: Use specific reversal agents when available (idarucizumab for dabigatran, andexanet alfa for factor Xa inhibitors) 2
- Check coagulation parameters before and after reversal 2
Antiplatelet agents: No specific reversal recommended routinely, but platelet transfusion may be considered in select cases requiring urgent surgery 2
Increased Intracranial Pressure Management
- Elevate head of bed 20-30 degrees 4
- Avoid hypoxia, hypercarbia, and hyperthermia - all exacerbate raised ICP 4
- Osmotherapy (mannitol or hypertonic saline) and hyperventilation for patients deteriorating from increased ICP or herniation 4
- Consider external ventricular drainage for hydrocephalus 4
- Surgical decompression for large cerebellar hemorrhages causing brainstem compression 4
Do not use corticosteroids - they are not effective for cerebral edema in hemorrhagic stroke 4
Seizure Management
- Treat new-onset seizures with short-acting medications (e.g., lorazepam IV) if not self-limiting 5
- Do not use prophylactic anticonvulsants - they are not recommended and may worsen outcomes 6
- Single self-limiting seizures within 24 hours do not require ongoing antiepileptic therapy 5
Inpatient Management (24 Hours to Discharge)
Monitoring and Complications
- Neurological assessments hourly for first 24 hours using validated scales 1
- Temperature monitoring every 4 hours for 48 hours, then per ward routine 5
- Treat fever >37.5°C with antipyretics and investigate for infection 5
- Monitor for hematoma expansion - 30-40% of patients continue bleeding in first hours 1
Venous Thromboembolism Prophylaxis
High-risk patients (immobile, unable to move lower limbs) require prophylaxis:
- Start intermittent pneumatic compression (IPC) devices within 24 hours if no contraindication 5
- Apply thigh-high IPC and continue until independently mobile, discharged, or 30 days (whichever first) 5
- Alternative: Low-molecular-weight heparin (enoxaparin) for ischemic stroke patients at high VTE risk; unfractionated heparin if renal failure 5
- Do not use anti-embolism stockings alone - they are ineffective 5
Critical timing: Wait until hemorrhage is stable before starting pharmacological VTE prophylaxis. IPC is safer in acute phase.
Early Mobilization
- Begin mobilization within 24-48 hours if medically stable 5
- Frequent, brief out-of-bed activity (sitting, standing, walking) 5
- Rehabilitation assessment by specialists within 48 hours of admission 5
- More intense early sessions are not beneficial - use clinical judgment 5
Secondary Prevention and Long-Term Management
Blood Pressure Control
Target BP <130/80 mmHg for long-term management after ICH 7, 3
- Use thiazide diuretics, ACE inhibitors, or angiotensin receptor blockers as first-line agents 3
- Calcium channel blockers are alternative options 3
- Regular monitoring and medication adherence are essential 7
Antithrombotic Therapy Resumption
This is highly individualized based on indication and hemorrhage etiology:
- For patients with strong indication (e.g., mechanical heart valve, atrial fibrillation with high stroke risk), consider resuming anticoagulation after careful risk-benefit assessment 8
- Timing of resumption depends on hemorrhage cause, location, and patient factors 8
- Avoid antiplatelet agents in the acute phase - no role within 24 hours 9
Lifestyle Modifications
- Mediterranean-type diet: high in vegetables, fruit, whole grains, fish, nuts, olive oil; low in red meat 7
- Regular exercise and weight control 7
- Smoking cessation and alcohol reduction 7
- Sodium restriction (<2000 mg/day) 7
Functional Assessment and Rehabilitation
- Screen for depression, cognitive impairment, and functional limitations 7
- Refer to rehabilitation specialists as needed 7
- Assess fitness to drive and need for assistance with activities of daily living 7
Subarachnoid Hemorrhage Specific Considerations
For aneurysmal SAH (distinct from primary ICH):
- Oral nimodipine to prevent vasospasm 10
- Maintain euvolemia, not hypervolemia 1
- Treat symptomatic vasospasm with induced hypertension first, then endovascular therapy if refractory 1
- Secure aneurysm within 24 hours when expert team available 10
Key distinction: SAH management differs significantly from primary ICH - nimodipine is beneficial for SAH but not primary ICH.